CEL-SCI Corp (CVM)
1.46
-0.01
(-0.68%)
USD |
NYAM |
Apr 24, 16:00
1.445
-0.02
(-1.03%)
After-Hours: 20:00
CEL-SCI Cash from Financing (TTM): 8.678M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.678M |
September 30, 2023 | 4.694M |
June 30, 2023 | 0.1569M |
March 31, 2023 | -1.143M |
December 31, 2022 | -0.3165M |
September 30, 2022 | -0.6384M |
June 30, 2022 | 0.1483M |
March 31, 2022 | 37.22M |
December 31, 2021 | 40.94M |
September 30, 2021 | 54.52M |
June 30, 2021 | 54.29M |
March 31, 2021 | 27.87M |
December 31, 2020 | 33.21M |
September 30, 2020 | 25.04M |
June 30, 2020 | 27.85M |
March 31, 2020 | 26.21M |
December 31, 2019 | 19.34M |
September 30, 2019 | 14.79M |
June 30, 2019 | 24.16M |
March 31, 2019 | 17.55M |
December 31, 2018 | 19.60M |
September 30, 2018 | 21.39M |
June 30, 2018 | 13.71M |
March 31, 2018 | 14.47M |
December 31, 2017 | 11.94M |
Date | Value |
---|---|
September 30, 2017 | 13.26M |
June 30, 2017 | 13.24M |
March 31, 2017 | 15.01M |
December 31, 2016 | 13.47M |
September 30, 2016 | 20.31M |
June 30, 2016 | 15.61M |
March 31, 2016 | 25.89M |
December 31, 2015 | 25.28M |
September 30, 2015 | 21.14M |
June 30, 2015 | 21.27M |
March 31, 2015 | 16.15M |
December 31, 2014 | 18.57M |
September 30, 2014 | 31.54M |
June 30, 2014 | 31.52M |
March 31, 2014 | 21.77M |
December 31, 2013 | 19.35M |
September 30, 2013 | 9.782M |
June 30, 2013 | 9.803M |
March 31, 2013 | 14.93M |
December 31, 2012 | 19.98M |
September 30, 2012 | 12.00M |
June 30, 2012 | 10.64M |
March 31, 2012 | 5.611M |
December 31, 2011 | 1.646M |
September 30, 2011 | 0.5659M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.143M
Minimum
Mar 2023
54.52M
Maximum
Sep 2021
20.90M
Average
24.16M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Boston Scientific Corp | 5.00M |
The Cigna Group | -4.294B |
Synlogic Inc | 20.94M |
BioXcel Therapeutics Inc | 26.52M |
IGM Biosciences Inc | 115.07M |